The current study is a continuation of our previous research, which focused on the role of other proteases such as metalloproteinases (MMP-9 and MMP-2) and their tissue inhibitors (TIMP-1 and TIMP-2) as candidates for tumor markers in gastro-intestinal malignancies, including CRC [19,20]. This evidence concerns the gene MMP9 and colorectal carcinoma.